Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

53.94
Delayed Data
As of Apr 25
 +0.39 / +0.73%
Today’s Change
46.01
Today|||52-Week Range
77.12
-7.70%
Year-to-Date
Exelixis (EXEL) Q1 Earnings: Will the Stock Disappoint?
Apr 25 / Zacks.com - Paid Partner Content
Intermediate Trade: Bristol-Myers Squibb
Apr 19 / TheStreet.com - Paid Partner Content
Bristol-Myers (BMY) to Post Q1 Earnings: What's in Store?
Apr 25 / Zacks.com - Paid Partner Content
Investors bet on Incyte drug success
Apr 19 / FT.com - Paid Partner Content
Headinvest, Llc Buys iShares Core S&P Small-Cap, Procter & Gamble Co, Exxon Mobil, .....
Apr 25 / GuruFocus News - Paid Partner Content
Roche's (RHHBY) Cancer Drug Gets FDA Nod for Label Expansion
Apr 18 / Zacks.com - Paid Partner Content
Rally Comes With Reasons for Concern
Apr 25 / TheStreet.com - Paid Partner Content
Bristol-Myers and Nordic Ink Biomarker Collaboration Deal
Apr 18 / Zacks.com - Paid Partner Content
T. Rowe Price Keeps Buying Philip Morris, Wells Fargo, Others
Apr 24 / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights: Alphabet, Amgen, Lowe's, Bristol-Myers and Priceli...
Apr 18 / Zacks.com - Paid Partner Content
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?
Apr 24 / Zacks.com - Paid Partner Content
Top Research Reports for Alphabet, Amgen & Lowe's
Apr 17 / Zacks.com - Paid Partner Content
3 Key Factors to Look Out for in Biogen's Q1 Results
Apr 24 / Zacks.com - Paid Partner Content
5 Major Drug Stocks Likely to Beat Q1 Earnings Estimates
Apr 17 / Zacks.com - Paid Partner Content
Douglas Lane & Associates, LLC Buys Morgan Stanley, IAC/InterActiveCorp, Lowe's, Sell...
Apr 21 / GuruFocus News - Paid Partner Content
Biogen to License Alzheimer Candidate from Bristol-Myers
Apr 17 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: J&J Slips on Mixed Q1, Lilly Hit by FDA CRL
Apr 21 / Zacks.com - Paid Partner Content
J&J (JNJ) to Kick Off Pharma Q1 Earnings: Will it Beat?
Apr 13 / Zacks.com - Paid Partner Content
Penn Davis Mcfarland Inc Buys Celgene, Bristol-Myers Squibb Company, Sells Teva Pharm...
Apr 20 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: Merck Gets CRL for Label Expansion Effort, Roche Cancer Drug To...
Apr 13 / Zacks.com - Paid Partner Content
Rothschild Investment Corp Buys Thermo Fisher Scientific, First Midwest Bancorp, Bri...
Apr 20 / GuruFocus News - Paid Partner Content
Bristol-Myers (BMY) Collaborates with Apexigen for Opdivo
Apr 12 / Zacks.com - Paid Partner Content
Sabal Trust CO Buys Enbridge, Lockheed Martin, Qualcomm, Sells Verizon Communications...
Apr 20 / GuruFocus News - Paid Partner Content
Activist Jana builds near 9% stake in Whole Foods
Apr 10 / FT.com - Paid Partner Content
Is J&J's Pharma Sales Slowdown a Warning for Other Players?
Apr 19 / Zacks.com - Paid Partner Content
Merck's Keytruda cancer drug records sales surge
Apr 03 / FT.com - Paid Partner Content